Borna Dhar

Analyzing the pulse of the global healthcare industry.
Market Researcher specializing in MedTech, Pharma, and Care Delivery trends.

[Next Move Strategy Consulting @NextMSC]

@PlatinumAnglo
@ImpalaPlatinum
@SIBSTILL -Stillwater
@NornickelGroup
@NorthamPlatinum

The real disruption isn’t EVs. It’s material switching.

[⭑ ⚝ TulipaDev ⚝ ⭑ @TulipaDev]

Hi, fellow game developers.

I’m here to show you my first little monster created for the 30 Years of Tamagotchi Jam!

I’ve discovered that I love drawing little monsters, so feel free to reach out if you need monsters for your games. ✨🕹

#pixelart #gamedev #1bit

[Borna Dhar @BornaD75458]

Key Players: @Astellas Pharma, @abbvie , @Bristol-Myers Squibb, @AstraZeneca , @Roche , @Celgene, @Merck

#CancerDrugMarket #Oncology #CancerTreatment #Pharma #Healthcare #MedicalInnovation

https://t.co/oxJ9RXfwnp

[Borna Dhar @BornaD75458]

Cancer Drug Market is growing steadily as demand for targeted therapies and immuno-oncology treatments rises globally.

Increasing cancer prevalence and strong R&D investments are expected to drive market growth through 2030.

[Borna Dhar @BornaD75458]

Key Players: @Nvidia Corporation, @enlitic Inc., @CloudMedx Health, @augmedix , @GE Healthcare, @Siemens Healthineers AG, @Nuance Communications

#HealthcareAI #DigitalHealth #AIHealthcare #HealthTech #MedicalAI #FutureOfHealthcare

https://t.co/egDYZC9GMY

[Borna Dhar @BornaD75458]

Healthcare AI Software Market is growing rapidly as AI transforms diagnosis, treatment planning, and hospital operations.

Driven by rising chronic diseases, healthcare digitization, and predictive analytics adoption, the market is expected to expand significantly by 2030.

[Borna Dhar @BornaD75458]

The 𝗗𝗧𝗖 𝘄𝗲𝗹𝗹𝗻𝗲𝘀𝘀 testing market is shifting from transactional kit sales to long-term, data-driven customer relationships.

𝗔𝗰𝗰𝗲𝘀𝘀 𝗙𝘂𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 : https://t.co/Y3VWaQ7HXO
𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗥𝗘𝗘 𝗦𝗮𝗺𝗽𝗹𝗲 : https://t.co/naQWPltVFx

[Borna Dhar @BornaD75458]

Most investors focus on: 𝘁𝗲𝘀𝘁 𝘃𝗼𝗹𝘂𝗺𝗲 𝗮𝗻𝗱 𝘀𝗵𝗼𝗿𝘁-𝘁𝗲𝗿𝗺 𝗸𝗶𝘁 𝘀𝗮𝗹𝗲𝘀.

They should actually be looking at: customer retention and repeat engagement.

𝗛𝗲𝗿𝗲 𝗶𝘀 𝘁𝗵𝗲 𝗿𝗲𝗮𝘀𝗼𝗻 𝘄𝗵𝘆: one-off purchases don’t scale recurring trust does.

[Borna Dhar @BornaD75458]

Speed sells analyzers, but reagent economics and cost per test decide who wins the coagulation hemostasis market.

𝗔𝗰𝗰𝗲𝘀𝘀 𝗙𝘂𝗹𝗹 𝗿𝗲𝗽𝗼𝗿𝘁-https://t.co/L3nYkGiNdI
𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲- https://t.co/XY4ZAdJS59

[Borna Dhar @BornaD75458]

Most investors in the 𝗖𝗼𝗮𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗛𝗲𝗺𝗼𝘀𝘁𝗮𝘀𝗶𝘀 𝗔𝗻𝗮𝗹𝘆𝘇𝗲𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 focus on analyzer speed.

They should actually be looking at reagent economics & cost per result.

Instruments are interchangeable, but reagents and workflow lock in long-term revenue.

[Borna Dhar @BornaD75458]

Investors in natural cold and cough remedies often chase brand hype, but true growth comes from trusted, efficacy-proven ingredients.

Access Full Report- https://t.co/PNB1Efs9KQ
Download Free Sample- https://t.co/F1Sp3O8scM

[Borna Dhar @BornaD75458]

Most investors focus on brand recognition in natural cold and cough remedies.

They should actually be looking at efficacy-backed ingredient trust.

Reason: Consumers increasingly prioritize scientifically validated relief over flashy marketing.

[Borna Dhar @BornaD75458]

A contrarian take on why procedure volume, not unit sales, is the real growth driver in the Medical Sealers Market.

Access Full Report- https://t.co/kfzW7nCFIW
Download Free Sample- https://t.co/klZI8P5bGu

[Borna Dhar @BornaD75458]

Most investors focus on unit sales in the Medical Sealers Market.

They should be looking at procedure volume growth.
Reason: sealers follow surgeries, not shipments MIS adoption drives real demand.

[Borna Dhar @BornaD75458]

In the ����𝗻𝗸𝗹𝗲 𝗦𝗽𝗹𝗶𝗻𝘁𝘀 𝗠𝗮𝗿𝗸𝗲𝘁, patient comfort and adherence matter more for revenue than sheer unit sales.

𝗔𝗰𝗰𝗲𝘀𝘀 𝗙𝘂𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁- https://t.co/ZFsNlMTnPq
𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲-https://t.co/PSuGz1F65q

[Borna Dhar @BornaD75458]

Most manufacturers focus on unit sales volume.
They should actually be looking at patient adherence and comfort metrics.

𝗛𝗲𝗿𝗲 𝗶𝘀 𝘁𝗵𝗲 𝗿𝗲𝗮𝘀𝗼𝗻 𝘄𝗵𝘆: a splint that patients refuse to wear drives revenue loss, not the number of units sold.

[Borna Dhar @BornaD75458]

𝗧𝗵𝗶𝘀 𝗶𝘀 𝘄𝗵𝗲𝗿𝗲 𝗻𝗲𝘅𝘁-𝗴𝗲𝗻 𝗺𝗶𝗰𝗿𝗼𝗰𝗮𝘁𝗵𝗲𝘁𝗲𝗿 𝗹𝗲𝗮𝗱𝗲𝗿𝘀 𝗮𝗿𝗲 𝗯𝗲𝗶𝗻𝗴 𝗯𝘂𝗶𝗹𝘁.

𝗔𝗰𝗰𝗲𝘀𝘀 𝗙𝘂𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 : https://t.co/u4Olbp4sb2
𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗥𝗘𝗘 𝗦𝗮𝗺𝗽𝗹𝗲 : https://t.co/wZWF8Dm8OT

[Borna Dhar @BornaD75458]

𝗠𝗼𝘀𝘁 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 𝗽𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲 𝘃𝗼𝗹𝘂𝗺𝗲.

𝗧𝗵𝗲𝘆 𝘀𝗵𝗼𝘂𝗹𝗱 𝗯𝗲 𝘄𝗮𝘁𝗰𝗵𝗶𝗻𝗴 𝗰𝗼𝗺𝗽𝗹𝗲𝘅-𝗰𝗮𝘀𝗲 𝗮𝗱𝗼𝗽𝘁𝗶𝗼𝗻.

𝗪𝗵𝘆: that’s where pricing power and real growth live.

[Borna Dhar @BornaD75458]

Most investors chase sales numbers, but real growth in mouthwash comes from tracking consumer ingredient trends.

𝗔𝗰𝗰𝗲𝘀𝘀 𝗙𝘂𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁- https://t.co/bgznjWDD2o
𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲- https://t.co/pgdMB2OiHe

[Borna Dhar @BornaD75458]

Most investors focus on 𝗠𝗼𝘂𝘁𝗵𝘄𝗮𝘀𝗵 sales volume.
They should actually be looking at consumer ingredient preferences.

𝗛𝗲𝗿𝗲 𝗶𝘀 𝘁𝗵𝗲 𝗿𝗲𝗮𝘀𝗼𝗻 𝘄𝗵𝘆: shifts toward natural, alcohol-free, and functional formulations are driving loyalty, not just bottle count.